UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

The Lancet (British edition), 2012-06, Vol.379 (9833), p.2243-2251

2012

Volltextzugriff (PDF)

Effect of Prolonged Sitting and Breaks in Sitting Time on Endothelial Function

Medicine and science in sports and exercise, 2015-04, Vol.47 (4), p.843-849

2015

Volltextzugriff (PDF)

Effects of Resistance Training on Adiposity and Metabolism after Spinal Cord Injury

Medicine and science in sports and exercise, 2012, Vol.44 (1), p.165-174

2012

Volltextzugriff (PDF)

Cell-Free DNA Fragments as Biomarkers of Islet β-Cell Death in Obesity and Type 2 Diabetes

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2151

2021

Volltextzugriff (PDF)

Clinical use of adiponectin as a marker of metabolic dysregulation

Baillière's best practice & research. Clinical endocrinology & metabolism, 2014-01, Vol.28 (1), p.107-117

2014

Volltextzugriff (PDF)

Mechanotransduction of shear in the endothelium: Basic studies and clinical implications

Vascular medicine (London, England), 2011-10, Vol.16 (5), p.365-377

2011

Volltextzugriff (PDF)

Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function

PloS one, 2018-05, Vol.13 (5), p.e0197080

2018

Volltextzugriff (PDF)

Analysis of serum Hsp90 as a potential biomarker of β cell autoimmunity in type 1 diabetes

PloS one, 2019-01, Vol.14 (1), p.e0208456-e0208456

2019

Volltextzugriff (PDF)

Quantitative trait loci, G×E and G×G for glycemic traits: response to metformin and placebo in the Diabetes Prevention Program (DPP)

Journal of human genetics, 2022-08, Vol.67 (8), p.465-473

2022

Volltextzugriff (PDF)

Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program

Diabetes (New York, N.Y.), 2008-04, Vol.57 (4), p.980-986

2008

Volltextzugriff (PDF)

Cardiovascular consequences of metabolic syndrome

Translational research : the journal of laboratory and clinical medicine, 2017-05, Vol.183, p.57-70

2017

Volltextzugriff (PDF)

Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans

Diabetes (New York, N.Y.), 2007-03, Vol.56 (3), p.728-734

2007

Volltextzugriff (PDF)

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

The New England journal of medicine, 2023-09, Vol.389 (10), p.877-888

2023

Volltextzugriff (PDF)

Recruitment effort and costs from a multi-center randomized controlled trial for treating depression in type 2 diabetes

Trials, 2019-11, Vol.20 (1), p.621-621, Article 621

2019

Volltextzugriff (PDF)

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

The lancet. Diabetes & endocrinology, 2022-06, Vol.10 (6), p.418-429

2022

Volltextzugriff (PDF)

No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir-Ritonavir in Healthy Subjects without HIV Infection: A Placebo-Controlled Trial

Clinical infectious diseases, 2008-08, Vol.47 (4), p.567-574

2008

Volltextzugriff (PDF)

Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications

The journal of clinical endocrinology and metabolism, 2001-11, Vol.86 (11), p.5457-5464

2001

Volltextzugriff (PDF)

Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort

PloS one, 2015-08, Vol.10 (8), p.e0136853-e0136853

2015

Volltextzugriff (PDF)

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

The Lancet (British edition), 2023-08, Vol.402 (10400), p.472-483

2023

Volltextzugriff (PDF)

Normalization of flow-mediated dilation to shear stress area under the curve eliminates the impact of variable hyperemic stimulus

Cardiovascular ultrasound, 2008-09, Vol.6 (1), p.44-44, Article 44

2008

Volltextzugriff (PDF)

Interactions Between Endothelin and Nitric Oxide in the Regulation of Vascular Tone in Obesity and Diabetes

Diabetes (New York, N.Y.), 2004-08, Vol.53 (8), p.2060-2066

2004

Volltextzugriff (PDF)

β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment

Diabetes care, 2014-06, Vol.37 (6), p.1751-1758

2014

Volltextzugriff (PDF)

Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes

Diabetes (New York, N.Y.), 2002-12, Vol.51 (12), p.3517-3523

2002

Volltextzugriff (PDF)

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

Basic research in cardiology, 2013-07, Vol.108 (4), p.365-365, Article 365

2013

Volltextzugriff (PDF)

Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program

BMJ open diabetes research & care, 2021-03, Vol.9 (1), p.e001953

2021

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(222)

Publikationsform

Artikel
(238)

Sprache

Englisch
(238)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

Effect of Prolonged Sitting and Breaks in Sitting Time on Endothelial Function

Effects of Resistance Training on Adiposity and Metabolism after Spinal Cord Injury

Cell-Free DNA Fragments as Biomarkers of Islet β-Cell Death in Obesity and Type 2 Diabetes

Clinical use of adiponectin as a marker of metabolic dysregulation

Mechanotransduction of shear in the endothelium: Basic studies and clinical implications

Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function

Analysis of serum Hsp90 as a potential biomarker of β cell autoimmunity in type 1 diabetes

Quantitative trait loci, G×E and G×G for glycemic traits: response to metformin and placebo in the Diabetes Prevention Program (DPP)

Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program

Cardiovascular consequences of metabolic syndrome

Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Recruitment effort and costs from a multi-center randomized controlled trial for treating depression in type 2 diabetes

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir-Ritonavir in Healthy Subjects without HIV Infection: A Placebo-Controlled Trial

Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications

Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Normalization of flow-mediated dilation to shear stress area under the curve eliminates the impact of variable hyperemic stimulus

Interactions Between Endothelin and Nitric Oxide in the Regulation of Vascular Tone in Obesity and Diabetes

β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment

Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program

Suchergebnisse filtern